Sharing the Decision Slide Set:
Index View

Terms of Use: This CDC slide set is in the public domain. You may reproduce these slides without permission as long as they are not changed in any way. However, if you wish to adapt and/or revise these slides, you must remove the CDC name, logo, and any other references prior to use. Failure to follow these procedures could result in legal action.

1. Screening for Prostate Cancer: Sharing the Decision
2. These Organizations Recommend a Form of Shared Decision Making for Prostate Cancer Screening
3. Today's Goals

4. Goal 1: Discuss What Is Known about the Risk of Prostate Cancer and Its Natural History
5. Risk of Prostate Cancer in 40 Year Old U.S. Men, to End of Life (per 1,000 Men)
6. Risk of Death for 40 Year Old U.S. Men, to End of Life, by Leading Causes
7. Prostate Cancer Trends in Incidence and Mortality, 1973–1999
8. Risk of Death from Prostate Cancer by Age and Race/Ethnicity
9. Risk of Prostate Cancer Diagnosis by Age and Race/Ethnicity
10. Natural History of Prostate Cancer
11. Prostate Cancers Vary in Their Natural Histories
12. Preventing Prostate Cancer
13. Summary

14. Goal 2: Discuss the Benefits and Harms of Prostate Cancer Screening and Treatment
    15. Key Issues of Screening and Early Treatment
    16. What Are the Potential Benefits of Screening?
    17. Prostate Cancer Incidence Rates by Stage, 1973–1995
    18. Finding Prostate Cancer Earlier Is Not Enough
    19. Can We Treat Early-Stage Prostate Cancer Effectively?
    20. Risk of Mortality from Prostate Cancer Among Men in a Randomized Trial
    21. What Happened to U.S. Prostate Cancer Mortality Rates as Screening Rates Increased?
    22. What Happens to Prostate Cancer Mortality Rates in the U.K., Where PSA Screening Is Rare?
    23. Do We Extend Men's Lives by Screening for Prostate Cancer?
    24. Are There Harms from Screening and Early Treatment?
    25. Harms: False Positives
    26. Overdiagnosis
    27. Overdiagnosis, Tumor Heterogeneity, and Life Expectancy
    28. Overdiagnosis
    29. Tumor Rates by Grade
    30. Side Effects of Treatment
    31. Summary

32. How Can I Decide Whether to Screen My Patients?
33. Should I Screen Higher-Risk Patients?

34. Goal 3: Discuss How Clinicians Can Use Shared Decision Making to Help Patients Decide Whether to Be Screened for Prostate Cancer
35. Informing Patients
36. Adding Shared Decision Making
37. Shared Decision Making for Other Clinical Decisions
38. Benefits of Shared Decision Making
39. What Is the Best Way to Use Shared Decision Making?
40. Inform Your Patient
41. Decision Aids to Help in Shared Decision Making
42. Decision Aids to Help in Shared Decision Making
43. Discuss His Questions and Concerns
44. Discuss Why Men Choose Different Options
45. Listen and Make a Joint Decision
46. Summary

47. CDC Activities and Resources Related to Prostate Cancer and Shared Decision Making